Burkly Linda
EVP, CHIEF SCIENTIFIC OFFICER
Burkly Linda has filed 6 SEC Form 4 filings (6 transaction rows) across 1 company, with disclosures dating back to 2025. 5 of those filings fall inside the rolling window. Most recent filing: Sep 4, 2026.
On the most recent filing, Burkly Linda is listed as EVP, CHIEF SCIENTIFIC OFFICER at Editas Medicine, Inc. Inside the rolling window, Burkly Linda reported no open-market purchases and 5 open-market sales totaling $20K in EDIT. The largest disclosed transaction in the window is a sale of 4,928 EDIT shares on Jul 28, 2026, worth $13K.
Companies traded
Other insiders at EDIT
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$20K
reported sales (SEC code S)
Companies
1
in the rolling window
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
| Date | Ticker | Type | Value |
|---|---|---|---|
| Sep 3, 2025 | EDIT | Sale | $2K |
Frequently asked questions
How many SEC Form 4 filings has Burkly Linda made?
Burkly Linda has filed 6 SEC Form 4 filings (6 transaction rows) across 1 company since 2025.
Which companies does Burkly Linda trade?
Burkly Linda has filed SEC Form 4 disclosures for 1 company, including EDIT.
When was Burkly Linda's most recent SEC Form 4 filing?
Burkly Linda's most recent SEC Form 4 filing on Tracefour is dated Sep 4, 2026.
What is Burkly Linda's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Burkly Linda is listed as EVP, CHIEF SCIENTIFIC OFFICER.
What is Burkly Linda's total buy and sell value in the current window?
Inside the rolling retention window, Burkly Linda bought $0 and sold $20K based on SEC Form 4 filings.
What was Burkly Linda's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 4,928 EDIT shares on 2026-07-28, worth $13K, per SEC Form 4 filings.